Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of BAG5 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Host species | Goat |
| Applications | ELISA |
More info about BAG5 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB7384 |
| Product name: | BAG5 polyclonal antibody |
| Product description: | Goat polyclonal antibody raised against synthetic peptide of BAG5. |
| Gene id: | 9529 |
| Gene name: | BAG5 |
| Gene alias: | BAG-5 |
| Gene description: | BCL2-associated athanogene 5 |
| Immunogen: | A synthetic peptide corresponding to human BAG5. |
| Immunogen sequence/protein sequence: | C-DGNRTDKNYIR |
| Protein accession: | NP_001015048.1;NP_001015049.1;NP_004864.1 |
| Form: | Liquid |
| Concentration: | 0.5 mg/mL |
| Recommend dilutions: | ELISA (1:16000) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Goat |
| Antigen species / target species: | Human |
| Specificity: | This antibody is expected to recognize reported isoforms a (NP_001015049.1) and b (NP_001015048.1, NP_004864.1). |
| Applications: | ELISA |
| Shipping condition: | Dry Ice |
| Publications: | BAG5 inhibits parkin and enhances dopaminergic neuron degeneration.Kalia SK, Lee S, Smith PD, Liu L, Crocker SJ, Thorarinsdottir TE, Glover JR, Fon EA, Park DS, Lozano AM. Neuron. 2004 Dec 16;44(6):931-45. |